Oct 21, 2026 08:32AM
Sep 28, 2026 07:01AM
Aug 31, 2026 08:32AM
Aug 6, 2026 07:50AM
May 7, 2026 07:45AM
May 4, 2026 04:06PM
Mar 12, 2026 12:26PM H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX): "significant upside potential exists"
Mar 5, 2026 11:33AM
Mar 5, 2026 07:06AM
Jan 20, 2026 07:00AM
Dec 10, 2025 08:31AM
Nov 10, 2025 02:33AM
Nov 6, 2025 07:59AM
Oct 14, 2025 08:01AM Lexicon presents additional pilavapadin data for diabetic nerve pain
Sep 22, 2025 04:00PM
Sep 11, 2025 06:50AM
Sep 9, 2025 06:50AM
Sep 8, 2025 08:31AM
Sep 3, 2025 06:50AM
Sep 2, 2025 08:33AM
Aug 7, 2025 08:09AM Lexicon Pharma (LXRX) PT Raised to $1.90 at Citi, Adds 90d Upside Catalyst Watch
Aug 6, 2025 12:06PM
Aug 6, 2025 07:32AM
Jun 24, 2025 06:52AM
May 13, 2025 04:01PM
Apr 2, 2025 08:01AM
Mar 31, 2025 06:46AM
Mar 28, 2025 07:30AM Lexicon Pharma (LXRX) Announces Exclusive License Agreement with Novo Nordisk for LX9851
Mar 6, 2025 04:01PM
Mar 4, 2025 06:46AM
Mar 3, 2025 07:01AM
Jan 3, 2025 08:23AM
Jan 2, 2025 08:04AM
Dec 12, 2024 06:47AM
Nov 25, 2024 06:39AM Lexicon Pharmaceuticals (LXRX) PT Lowered to $4 at H.C. Wainwright
Nov 22, 2024 07:33AM
Nov 20, 2024 04:06PM
Nov 12, 2024 04:10PM
Nov 12, 2024 04:05PM
Nov 1, 2024 07:22AM
Nov 1, 2024 06:40AM
Oct 31, 2024 07:01AM Lexicon Pharma (LXRX) Halted, News Pending
Oct 23, 2024 09:05AM
Oct 18, 2024 05:48AM
Oct 17, 2024 07:53AM
Oct 17, 2024 06:55AM
Oct 16, 2024 04:35PM
Oct 10, 2024 07:40AM
Oct 3, 2024 06:57AM H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX)
Sep 30, 2024 07:26AM

468,767 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All